AI-generated content for informational purposes only. Not financial advice. Always do your own research.

Sobre

A Synopsys é a líder mundial em software de automação de design eletrônico usado por designers de chips para arquitetar, simular e verificar designs de semicondutores antes da fabricação. A empresa também fornece blocos de IP silício e ferramentas de teste de segurança de aplicações, dando-lhe múltiplos fluxos de receita vinculados à indústria de chips. Os investidores valorizam a Synopsys por seu papel essencial na viabilização de cada nova geração de processadores, de chips móveis a aceleradores de IA.

Ações de IA

As ferramentas de design de chip orientadas por IA da Synopsys reduzem drasticamente o tempo e o custo de criação de aceleradores de IA personalizados, posicionando a empresa como um habilitador e beneficiário do boom da inteligência artificial.

Ações de Crescimento

Com uma posição quase de duopólio em software EDA, um negócio de IP de silício em crescimento e aplicações expandidas em testes de segurança, a Synopsys oferece crescimento de receita sustentável de dois dígitos altos com receita recorrente elevada.

Ações de Tecnologia

A Synopsys fornece o software de automação de design eletrônico que os designers de chips usam para criar cada novo processador, tornando-a uma ferramenta indispensável no ecossistema da tecnologia de semicondutores.

Key Financials SNPS

Preço $437.09
Variação (1D) +3.25%
Variação (30D) -6.95%
Variação (60D) +12.01%
Variação (90D) -8.60%
Variação (180D) -5.48%
Variação (1Y) -14.25%
Variação (5Y) +57.14%
P/E Ratio 73.46
EPS (TTM) $5.95
Faixa de 52 Semanas $365.74 — $651.73
MA de 50 Dias $475.85
Volume 1.74M

Data updated Feb 15 · Source: Twelve Data

4.3
2 reviews
Market Opportunity
4.7
AI Technology Leadership
4.5
Company Fundamentals
4.2
Management Execution
4
Stock Performance
2.3
Claude Opus 4.6
AI Review
4.1/5

Synopsys is the undisputed leader in electronic design automation (EDA), providing essential software tools for semiconductor chip design"a critical enabler of the AI revolution. The company holds a dominant duopoly position alongside Cadence Design Systems, creating a formidable competitive moat with extremely high switching costs.

The bull case centers on secular tailwinds: surging AI chip complexity drives demand for increasingly sophisticated design tools, and Synopsys is embedding AI directly into its platforms (DSO.ai) to accelerate chip development. Revenue growth has been consistently strong, and the pending Ansys acquisition could create a powerful design-to-simulation platform.

However, the current valuation demands scrutiny. A P/E of 73.5x is steep, and the stock sits roughly 33% below its 52-week high, reflecting investor concerns about growth deceleration and regulatory risks around the Ansys deal. The 14% decline over the past year underperforms the broader tech sector significantly.

The bear case includes potential antitrust complications, customer concentration in cyclical semiconductor firms, and a premium valuation that leaves little margin for disappointment. Still, Synopsys's mission-critical position in chip design makes it a high-quality long-term holding, though current prices may warrant patience for a better entry point.

Market Opportunity
4.7
AI Technology Leadership
4.5
Company Fundamentals
4.2
Management Execution
4
Stock Performance
2.3
Feb 15, 2026
Gemini 3 Pro Preview
AI Review
4.4/5

Synopsys (SNPS) stands as a critical infrastructure play in the semiconductor industry, holding a dominant duopoly position in Electronic Design Automation (EDA). As the demand for AI-optimized hardware accelerates, chipmakers rely heavily on Synopsys software to manage increasing design complexity. The company's integration of AI into its own tool suite enhances its competitive moat and recurring revenue potential. However, the investment case requires caution regarding valuation; with a P/E ratio exceeding 73 and the stock trading significantly below its 52-week high of $651, expectations are high while technical momentum is currently bearish. Additionally, the complex pending acquisition of Ansys introduces execution risk and uncertainty regarding capital allocation. While the long-term thesis is robust given the secular trends in silicon, the current premium valuation suggests limited margin for error for short-term investors.

Feb 12, 2026
Synopsys Screenshot

Added: Feb 11, 2026

synopsys.com

Latest from Otrai

How to Trade Stock Indices: S&P 500, Nasdaq, and Dow via ETFs, Futures, and CFDs

How to Trade Stock Indices: S&P 500, Nasdaq, and Dow via ETFs, Futures, and CFDs

A stock index is a single number that summarizes the price action of a basket of companies. The S&P 500 tracks roughly 500 large US firms, the Nasdaq-100 tracks the 100 largest non-financial names on the Nasdaq exchange, and the Dow Jones Industrial Average follows 30 blue-chip stocks.

The Options Greeks Explained: Delta, Gamma, Theta, and Vega

The Options Greeks Explained: Delta, Gamma, Theta, and Vega

The Greeks explain why an option costs what it costs and how that price changes when the stock moves, time passes, and volatility shifts. Delta, Gamma, Theta, and Vega, made accessible.

Chart Patterns That Actually Work: Head & Shoulders, Triangles, Flags & Double Tops

Chart Patterns That Actually Work: Head & Shoulders, Triangles, Flags & Double Tops

Chart patterns are the most recognizable part of technical analysis and the most misunderstood. Most fail or break out the wrong way before reversing. This guide covers head and shoulders, double tops and bottoms, triangles, and flags — with realistic reliability, target measurement, and false-breakout confirmation.

Como Fazer Backtest de uma Estratégia de Trading: Métodos, Armadilhas e O Que os Resultados Realmente Significam

Como Fazer Backtest de uma Estratégia de Trading: Métodos, Armadilhas e O Que os Resultados Realmente Significam

Todo trader tem uma estratégia que parece ótima em sua cabeça. Backtesting é como você descobre se ela realmente funciona. Aqui está como testar estratégias adequadamente, quais métricas importam e por que a maioria dos resultados de backtest é boa demais para ser verdade.